The early and marked upregulation of VCAM-1 makes this molecule a potential early biomarker for detecting metastatic activity, offering advantages over traditional imaging markers that may not clearly distinguish between tumour stages or identify early metastatic spread. The gene discussed is VCAM1; the disease is neoplasm.